Kowa Company, Ltd.

This study compared a new controlled-release version of the cholesterol drug pemafibrate to the standard version. It involved 60 adults with high triglycerides and other blood fat problems. The goal was to see if the new version worked as well, was safe, and how the body processe…

This study tested a new medication called K-877 (pemafibrate) for people with high cholesterol who cannot tolerate standard statin drugs due to side effects. It involved 71 adult patients who took either a low dose, a higher dose, or a placebo pill for 12 weeks. The goal was to s…

This study tested the safety and effectiveness of a new extended-release pill (K-877 ER) for lowering high triglycerides, a type of fat in the blood, over one year. It involved 121 adults with dyslipidemia who took the pill daily, with the dose adjusted if needed. The goal was to…